AGL Stock Recent News

The provider of support services for primary care physicians anticipates medical margins for fiscal 2023 of between $340 million and $360 million, down from an earlier forecast of $455 million to $470 million.

Shares of Agilon Health Inc. AGL, -0.25% were indicated down more than 1% in Friday's premarket, after the health care services company lowered its 2023 margin outlook, citing higher costs, but provided an upbeat 2024 outlook. “Higher-than-expected costs became visible to us in mid-December during the November close process given updated data from health plans and will impact our FY2023 medical margins,” said Chief Executive Steve Sell.

agilon health's full-year outlook caused its stock to fall sharply, raising concerns about the sustainability of its business model. While the company reported a 71% increase in revenue and a rise in Medicare Advantage membership, its gross profit growth doesn't hold up. A $5 billion market cap appears too high, considering agilon's low medical margins.

Start Time: 16:30 January 1, 0000 5:29 PM ET agilon health, inc. (NYSE:AGL ) Q3 2023 Earnings Conference Call November 02, 2023, 16:30 PM ET Company Participants Steve Sell - CEO Tim Bensley - CFO Matthew Gillmor - VP, IR Conference Call Participants Lisa Gill - JPMorgan Justin Lake - Wolfe Research Stephen Baxter - Wells Fargo Gary Taylor - Cowen Jailendra Singh - Truist Securities George Hill - Deutsche Bank Whit Mayo - Leerink Partners Adam Ron - Bank of America Jamie Perse - Goldman Sachs Elizabeth Anderson - Evercore ISI Thomas Kelliher - RBC Capital Markets Jack Wallace - Guggenheim Operator Hello, everyone.

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2023 after the market closes on Thursday, November 2, 2023, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international.

agilon health expects positive adjusted EBITDA in 2023 and is experiencing double-digit net sales growth. The company's growth is driven by an increase in the number of members and partnerships with local physicians. Economies of scale, marketing efforts, and potential M&A could lead to significant free cash flow generation.

agilon health, inc. (NYSE:AGL ) Q2 2023 Earnings Conference Call August 3, 2023 4:30 PM ET Company Participants Matthew Gillmor - Vice President, Investor Relations Steve Sell - Chief Executive Officer Tim Bensley - Chief Financial Officer Conference Call Participants Lisa Gill - JPMorgan Jailendra Singh - Truist Securities Stephen Baxter - Wells Fargo Securities Gary Taylor - Cowen Whit Mayo - Leerink Partners Adam Ron - Bank of America George Hill - Deutsche Bank Sandy Draper - Guggenheim Securities Jamie Perse - Goldman Sachs Elizabeth Anderson - Evercore ISI David Larsen - BTIG Operator Welcome to the agilon health Second Quarter 2023 Earnings Conference.

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon Health (AGL) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.04 per share a year ago.